Herpes Simplex Virus Type 2 Serostatus Is Not Associated with Inflammatory or Metabolic Markers in Antiretroviral Therapy-Treated HIV

Systemic inflammation and immune activation may persist in HIV-infected persons on suppressive combination antiretroviral therapy (cART) and contribute to adverse health outcomes. We compared markers of immune activation, inflammation, and abnormal glucose and lipid metabolism in HIV-infected adults...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:AIDS Res Hum Retroviruses
Egile Nagusiak: Tan, Darrell H.S., Raboud, Janet M., Szadkowski, Leah, Yi, Tae Joon, Shannon, Brett, Kaul, Rupert, Liles, W. Conrad, Walmsley, Sharon L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Mary Ann Liebert, Inc. 2015
Gaiak:
Clinical Trial/Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4348084/
https://ncbi.nlm.nih.gov/pubmed/25399537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2014.0183
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak